This highly popular recent release is characterized by very large floral bracts, is disease resistant, and has an attractive growth habit. Photos courtesy of W. Ebert, Rutgers' European licensee.
This highly popular recent release is characterized by very large floral bracts, is disease resistant, and has an attractive growth habit. Photos courtesy of W. Ebert, Rutgers' European licensee.
Generated streamline visualizations of cardiac blood flow. The color at a point within a streamline is chosen to distinguish velocity - red streamlines signify fast moving blood, while blue streamlines represent lower speeds. In order to disambiguate direction, a small number of arrows were added within the streamline to point the way blood is flowing.
Depending on reaction conditions and parameters, the hydroxyapatite crystallization will form various sizes and morphologies: needles, hexagons, barrels, coral, spheres, dendrites, plates, and leaves, with sizes from 50nm to 5µm.
Rutgers scientists have developed single-stranded oligonucleotides that inhibit gene-specific RNA biosynthesis by a novel mechanism of action. This enables the development of highly efficient gene silencing agents that show unprecedented inhibitory levels in cell culture and has great promise in vivo.
The U1 adaptor enables very significant improvements over existing RNAi approaches because the U1 Adaptor is more stable and deliverable due to its chemically flexible platform. It can also be used in tandem with current RNAi technology to give deep silencing.
Rutgers scientists have discovered a new type of lipid in a virus that infects the phytoplankton E. huxleyi. This lipid dramatically affects phytoplankton apoptosis (programmed cell death), and the complete biosynthetic pathway has been determined. In E. huxleyi, the increased role of apoptosis has seriously reduced the number of phytoplankton, which disrupts Earth's carbon cycle and increases global warming. Also, scientists are currently questioning why healthy cells undergo apoptosis and cancerous cells do not. Studies of the new lipid from the virus affecting E. huxleyi may help scientists understand how to induce or reactivate apoptosis in cancerous cells and prevent further global warming.
OTC serves as a bridge between Rutgers researchers and commercialization partners providing patenting, marketing, licensing, and other commercialization support.
The OTC Transitions Rutgers academic discoveries into commercial successes. Download OTC Annual Report
About the Rutgers-UMDNJ Integration
The New Jersey Medical and Health Sciences Education Restructuring Act provides for most schools and units of UMDNJ to be transferred to Rutgers, effective July 1, 2013. As a result of this integration, you will see changes to this website. Learn more about the Rutgers-UMDNJ Integration .
The New Jersey Medical and Health Sciences Education Restructuring Act provides for most schools and units of UMDNJ to be transferred to Rutgers, effective July 1, 2013. As a result of this integration, you will see changes to this website. Learn more about the Rutgers-UMDNJ Integration .
Welcome to the Office of Technology Commercialization at Rutgers also known as the OTC.
Success through Innovation
Creating knowledge and transmitting it to present and future generations is the very essence of a research university. Students and faculty at Rutgers, The State University of New Jersey are creating new discoveries and technology in numerous disciplines including agriculture, engineering, computing, physical sciences, energy, life sciences and pharmaceuticals.
At the Office of Technology Commercialization, we serve as a bridge between Rutgers researchers and commercialization partners, ensuring the smooth and fast transfer of intellectual property created at the University.
We:
- Transfer the inventions of Rutgers faculty into practical applications, via licenses and start-up companies so that they benefit society on a local, national and global basis
- Educate and serve as a resource for the Rutgers community on matters relating to intellectual property, technology commercialization and entrepreneurship.
- Protect intellectual property via trademarks and patents
- Market technologies to companies, entrepreneurs and investors via numerous channels
- Negotiate patent licenses
- Assist in start-up company creation
In pursuit of our objectives, Rutgers, the flagship comprehensive public research university, has maintained a patenting and technology commercialization program for over 20 years.
Success through Commercialization
The Office of Technology Commercialization turns Rutgers academic discoveries into commercial successes. We move technology from the academic environment to the commercial sector. In doing so, we provide patenting, marketing, licensing, start-up company formation and other commercialization support to our student and faculty researchers at three campuses throughout New Jersey.
Patent Hall of Fame
- Congratulations to the following Rutgers inventors who were recently issued patents
| Patent | Issued | Inventor(s) | Title |
|---|---|---|---|
| 8,389,721 | 3/05/2013 | LaVoie, Edmond J. Liu, Leroy F. |
Solubilized topoisomerase poisons |
| 8,389,700 | 3/05/2013 | Langrana, Noshir A. Lin, David C. |
Agent delivery system capable of selectively releasing an agent |
| 8,377,915 | 2/19/2013 | Gorelick-Feldman, Jonathan Raskin, Ilya |
Methods for treating or preventing disorders using ecdysteroid compositions |
| 8,377,683 | 2/19/2013 | Lu, Yicheng. Reyes, Pavel Ivanoff Boustany, Nada N. | Zinc oxide-based nanostructure modified QCM for dynamic monitoring of cell adhesion and proliferation |
| 8,372,839 | 2/12/2013 | Ebright, Richard H. Wang, Dongye |
Bipartite inhibitors of bacterial RNA polymerase |
| 8,367,419 | 2/5/2013 | Li, Jing Lan, Anjian Li, Kunhao |
Compositions and methods for detection of explosives |
| 8,367,110 | 2/5/2013 | Kohn, Joachim B. Khan, Issac John Iovine, Carmine P. |
Polymeric drug delivery compositions and methods for treating ophthalmic diseases |
| 8,361,453 | 1/29/2013 | Uhrich, Kathryn E. Carbone, Ashley |
Iodinated polymers |
| 8,354,246 | 1/15/2013 |
Ebright, Richard H. Mukhopadhyay, Jayanta Severinov, Konstantin Semenova, Ekaterina |
Non-MCCJ25-related lariat-peptide inhibitors of bacterial RNA polymerase |
| 8,343,971 | 1/1/2013 | Laskin, Jeffrey D. Heck, Diane E. Lacey, Carl Jeffrey Aponte, Erik Huang, Mou-Tuan Heindel, Ned D. |
Pharmacologically-active vanilloid carbamates |
| 8,343,941 | 1/1/2013 | Gunderson, Samuel Ian Goraczniak, Rafal |
Compositions and methods for gene silencing |
| 8,337,904 | 12/25/2012 | Riman, Richard E Suchanek, Wojciech Shuk, Pavel TenHuisen, Kevor S. Chen, Chun-Wei |
Magnesium-substituted hydroxyapatites |
| 8,332,632 | 12/11/2012 | Iftode, Liviu Xu,Gang |
Method and system for execution monitor-based trusted computing |
| 8,313,802 | 11/20/2012 | Riman, Richard E Atakan, Vahit |
Method of hydrothermal liquid phase sintering of ceramic materials and products derived therefrom |
| 8,295,575 | 10/23/2012 | Feldman, Michael D. Viswanath, Satish Tiwari, Pallavi Toth, Robert Madabhushi, Anant |
Computer assisted diagnosis (CAD) of cancer using multi-functional, multi-modal in-vivo magnetic resonance spectroscopy (MRS) and imaging (MRI) |
| 8,288,590 | 10/16/2012 | Kohn, Joachim B. Bolikal, Durgadas Schut, Jaap Baluca, Ernest G. |
N-substituted monomers and polymers |
| 8,287,914 | 10/16/2012 | Riman, Richard. Sever, Christina |
Biomimetic hydroxyapatite synthesis |
| 8,280,132 | 10/02/2012 | Madabhushi, Anant Doyle, Scott Feldman, Michael D. Tomaszewski, John E. |
Malignancy diagnosis using content-based image retreival of tissue histopathology |
| 8,263,060 | 9/11/2012 | Uhrich, Kathryn E. Kim, Young Mi |
Fast degrading polymers |
| 8,252,887 | 8/28/2012 | Bolikal, Durgadas Brandom, Don K. Kabalnova, Lioubov Baluca, Ernest G. Kohn, Joachim |
Biocompatible polymers for medical devices |
| 8,241,668 | 8/14/2012 | Uhrich, Kathryn E. |
Therapeutic polyesters and polyamides |
| 8,232,322 | 7/31/2012 | East, Anthony Letton, Alan Kanamathareddy, Suseela Pudil, Bryant J. Goodrich, Stephen Hicks, Michael |
High molecular weight polymers, devices and method for making and using same |
| 8,231,543 | 7/31/2012 | Benasich, April A. Nawyn, Jason Roesler, Cynthia P. Realpe-Bonilla, Teresa Choudhury, Naseem |
Methods and systems for screening and treatment of young infants demonstrating deficits in auditory processing |
| 8,221,790 | 7/17/2012 | Uhrich, Kathryn E. | Therapeutic polyesters and polyamides |
| 8,218,836 | 7/10/2012 | Metaxas, Dimitris Banerjee, Debabr |
System and methods for generating three-dimensional images from two-dimensional bioluminescence images and visualizing tumor shapes and locations |
| 8,206,898 | 6/26/2012 | Ebright, Richard H. | RNA exit channel: target and method for inhibition of bacterial RNA polymerase |
| 8,204,315 | 6/19/2012 | Madabhushi, Anant Feldman, Michael D. Tomaszewski, John E. Rosen, Mark Shi, Jianbo |
Systems and methods for classification of biological datasets |
| 8,198,021 | 6/12/2012 | Ebright, Richard H. |
Target and method for inhibition of bacterial RNA polymerase |
| 8,192,754 | 6/05/2012 | Uhrich, Kathryn E.Tian, Lu |
Micelle assemblies |
| 8,187,806 | 5/29/2012 | Buyske, Steven Stenroos, Edward S. Johnson, William G. |
Association of GSTM1 with autism and assays and methods based thereon |
| 8,187,802 | 5/29/2012 | White, Eileen Strohecker, Anne Marie Mathew, Robin Karp, Cristina |
Cell lines useful for assessing modulation of autophagy |
| 8,185,551 | 5/22/2012 | Kuszmaul, Bradley C. Bender, Michael A. Farach-Colton, Martin |
Disk-resident streaming dictionary |
| 8,183,395 | 5/22/2012 | Falkowski, Paul Andrianasolo, Eric H. Haramaty, Liti White, Eileen Lutz, Richard |
Compositions and methods for treating cancer |
| 8,173,163 | 5/08/2012 | Kohn, Joachim B. Khan, Isaac John Lovine; Carmine P. |
Polymeric drug delivery compositions and methods for treating ophthalmic diseases |
| 8,164,345 | 4/24/2012 | Bushnell, Michael L. Ausoori, Raghuveer Khan, Omar Mehta, Deepak Chen, Xinghao |
Spectral and information theoretic method of test point, partial-scan, and full-scan flip-flop insertion to improve |
| 8,147,863 | 4/03/2012 | Kohn, Joachim B. Pulapura, Satish Schwarz, Arthur Bahulekar, Raman |
Polyarylates for drug delivery and tissue engineering |
| 8,143,474 | 3/27/2012 | Maliga, Pal |
Compositions and methods for increasing transgene expression in the plastids of higher plants |
| PP22,541 | 3/06/2012 | Vorsa, Nicholi |
Cranberry plant named `CNJ95-20-20` |
| 8,124,051 | 2/28/2012 | Minko, Tamara Sinko, Patrick J. Stein, Stanley |
Complex drug delivery composition and method for treating cancer |
| 8,121,347 | 2/21/2012 | Metaxas, Dimitris Kanaujia, Atul |
System and method for detecting and tracking features in images |
| 8,114,951 | 2/14/2012 | James, Ken Brochini, Stephen Tangpasuthadol, Varawut Kohn, Joachim |
Preparation and uses of polyarylates |
| 8,114,583 | 2/14/2012 | Ebright, Richard E. |
Switch-region: target and method for inhibition of bacterial RNA polymerase |
| 8,114,367 | 2/14/2012 | Riman, Richard E. Atakan, Vahit |
Systems and methods for carbon capture and sequestration and compositions derived therefrom |
Disclosure Wall of Fame
| RU Tech ID | Primary Inventor (as listed on disclosure form) |
|---|---|
| 2013-107 | Eileen White |
| 2013-108 | Richard Ludescher |
| 2013-109 | Girsh Blumberg |
| 2013-110 | Jing Li |
| 2013-111 | Dunbar Birnie |
| 2013-112 | Jeffrey Laskin |
| 2013-113 | Glenn Amatucci |
| 2013-114 | Gaeetano Montelione |
| 2013-115 | Prateek Prasannao |
| 2013-116 | Richard Ebright |
| 2013-117 | Rong Di |
| 2013-118 | Thomas Nosker |
| 2013-119 | Kishore Ramachandran |
| 2013-120 | Kathryn Uhrich |
| 2013-121 | Ilya Raskin |
| 2013-122 | Ilya Raskin |
Copyright © 2012, Rutgers, The State University of New Jersey, an equal opportunity, affirmative action institution.
Contact RU-info at 732-445-info (4636) | Have a question? Ask Colonel Henry.